Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
How many shares are outstanding right now?
Another reverse split coming? Soon enough it will be back under $1
They will use it on whatever they like, no matter what they "said."
They are burning cash like crazy and they are bonused on how much cash they raise by dilution investors.
Don't forget In Germany, Aurora has the top-two best selling flower products. "The company notes that Germany is the largest cannabis market in the EU, with 83 million citizens, and the new leadership in the country favors recreational legalization. "
The question I have is what are they ready to pounce on with this cash. Per the cc they were clear what it's not going to be used for.
Work together on what???
I believe the numbers. You believe what management wants you to believe.
One of those strategies has resulted in a 98% loss of share price.
(hint: the numbers don't lie.)
Ok. So the proper address back then would have been to point out the 450M was stated at the cc which already included the 17m new shares. Geez. Work together person... I was more bent out of shape the 17m came after the cc.. good to know. It still stands what he said in the cc for the $.
Nope. You were off by $90m. Your exact post is right here.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=168021317
"They had 450M already in cash. "
And now France is the savior?
How many countries have been the saviors before this?
The numbers and share price tells the tale no matter how things are spun.
Lol. Ok. I was 5m off so I'll give you that. I believe i posted about the dilution already as i post both good and bad and my opinions.. what this board is meant for. Btw, did you see the news today in regards to France? I believe he mentioned our next shipment to France in the last cc as well.
March 1 may not go down in history as a revolutionary date in France—like, say, the July standbys such as Bastille or Independence Day—but it will still stand as a significant one in the world of cannabis.
The French government has finally seen the light and announced that medical cannabis is here to stay. They have, as a result, now agreed to a decree authorizing the medical cultivation, manufacture, and distribution of medical cannabis in the country as of today.
https://hightimes.com/news/france-moves-to-begin-cultivating-medical-cannabis/
I don't have a problem with looking beyond a simple google search for you.
That was AFTER they sold the additional $90m is shares. You claimed it was before.
Your claim about it being before they did the placement was not correct. Details matter.
That was AFTER they sold the additional $90m is shares. You claimed it was before.
Your claim was in error. Details matter.
O geez. I didn't have the name of the person. Here it is for you. Awesome I can help on this clarification!
Aurora Cannabis, the Canadian company defining the future of cannabinoids worldwide, announced its financial and operational results for the second quarter fiscal 2022 ended December 31, 2021. "During the second quarter, we improved our Adjusted EBITDA by $2.5 million over Q1, moving us closer to our profitability goal. Our focus remains on further cost reductions, and we are pleased to announce today that we expect to reach the high end of the $60 to $80 million range. Our balance sheet remains among the strongest in the industry, with approximately $445 million in cash as of yesterday. This gives us significant working capital to support organic growth and positions us to pursue strategic M&A opportunities," stated Miguel Martin, Chief Executive Officer of Aurora.
I don't have a problem doing your google search.
"So let's begin with a few key highlights. We have one of the strongest balance sheets among Canadian LPs, including approximately $445 million in cash as of yesterday, no term debt and access to a USD 1 billion shelf perspective. This prospectus includes a USD 300 million ATM, from which we have recently drawn down nearly USD 90 million, meant to position us to take advantage of strategic M&A opportunities in the future. Our cash flow continues to improve with $20.3 million used in operating working capital in Q2 compared to $67.3 million in the same period of last year."
"Credit facility terms improved including maturity extension to December 2022
~$450 million of cash on balance sheet & improving cashflow positions company to drive sustainable, long-term revenue growth"
It doesn't say a word about them having the $450M in cash you claimed they had.
Awesome input and thank you! I don't think anyone added this interview of the ceo here.
If one listening to the cc and what the interview echos what was said in the cc, it does help explain... be it if you trust or not trust what he says...it's just another data point.
https://www.cnbc.com/video/2022/02/10/were-the-number-one-medical-business-in-canada-aurora-cannabis-ceo-on-earnings.html
A good article about why ACB is where it is.
Why Are Dark Clouds Still Looming Over This Pot Stock?
https://www.fool.com/investing/2022/02/26/why-are-dark-clouds-still-looming-over-this-pot-st/
Some notable quotes:
"It doesn't come as a surprise anymore when Canadian cannabis grower Aurora Cannabis reports disappointing quarterly results. The company has been on a roller-coaster ride for the last few years, failing to rebound. This year doesn't look any different. "
"Declining revenue has become a regular occurrence for Aurora Cannabis. In its recent second quarter (ended Dec. 31, 2021), Aurora's total net revenue declined 10% year over year to 60 million Canadian dollars."
"Aurora has missed achieving its positive target for earnings before interest, taxes, depreciation, and amortization multiple times by now, making investors skeptical."
"But this kind of heavy dilution doesn't sit well with investors, which is evident from its declining stock price. "
"But with it consistently missing its targets, it's hard to believe it will be EBITDA positive by next year. "
$332M USD DOES NOT equate to $450M CAD
Show where you got your $450M from.
At the end of the last quarter they had $332M in cash, not the $450M you want to claim. They had burned through $90M in cash in 6 months.
Given a 21% share price decline since earning were announced, I would say investors are not very pleased with the actual numbers and the additional dilution.
https://www.sec.gov/Archives/edgar/data/1683541/000127956922000209/ex991.htm
Too funny. Here are a couple of things you may want to take note of:
1) Insider sales are typically not perceived as positive events.
2) Shares obtained by insiders through grants are paid for by shareholders. It is free money for the insider.
So with the about 17M shares that are in the float now, as it was 198M, do you think that is to support the salaries of the CEO and directors? They had 450M already in cash. That would be some pretty massive raises! Thoughts?
Thanks for all the knowledge you bring here to discuss our investment! Here is another fact about the company.
Aurora Cannabis Inc. (TSE:ACB) Senior Officer Andre Jerome sold 6,916 shares of the stock in a transaction that occurred on Friday, February 18th. The stock was sold at an average price of C$5.31, for a total value of C$36,719.81. Following the completion of the transaction, the insider now owns 31,674 shares in the company, valued at approximately C$168,169.94.
Please don't focus on me as I'm already overconfident enough with a big ego. As for acb, this new management has a mission that seems logical to me. It's OK we have different opinions, but let's not get personal and keep the focus on the company.
I'm wondering how that strategy is working out?
When the numbers said that EBITDA positive wouldn't happen you said, "But cam said so" and "the midas letter said so." The numbers were right.
Then you said, "but cam really meant the next quarter." (The beginning of the perennial next quarter timeframe.) The numbers were right.
When the numbers said that the new EBITDA positive goal wouldn't happen you said, "But Singer said so." The numbers were right.
When the numbers showed the company was bleeding cash and new ATMs were announced you said, "they'll only use it if they have to, and they don't have to." The numbers were right.
Now you want to imply that somehow, more dilution is something other than what it is. Given the record of the numbers showing the real story and your constant support of "inaccurate" management statements I wonder how that will work out? During that time management has continued to collect huge bonuses but shareholders have lost 98% of their money.
Yup, next quarter, next year.
The numbers tell the real story.
Yeah. People need to listen to the cc to understand the numbers. He was pretty clear .
Outstanding Shares
198,572,414
02/03/2022
For those "half full" people who thought they were finished with selling shares, here is what the company claims they still can sell,
"As of December 31, 2021, the Company has access to the following capital resources available to fund operations and obligations:
• $332.4 million cash and cash equivalents; and
• US$1.0 billion securities registered for sale under the 2021 Shelf Prospectus filed on March 30, 2021 (the “2021 Shelf Prospectus”) for future financings or issuances of securities, including US$300 million available securities for sale under the 2021 at-the-market (ATM) program (the “ATM Program”).
"
https://www.sec.gov/Archives/edgar/data/1683541/000127956922000209/ex991.htm
They aren't close to the end of selling shares.
Yup, contrary to what some here claimed, they are not finished selling shares.
Hey but wont they just sell more in the future
Their main product is shares, not pot.
This has been denied by some here but the company admits it clearly in their releases.
"Subsequent to Q2 2022, the Company issued 19,595,000 common shares for gross proceeds of US$89.7 million under the ATM program."
The company's Q2 2022 ended less than 2 months ago. That's $45 million per month selling shares instead of pot.
That far outpaces their pot revenue. But yet, management will be happy with the bonuses.
Oh, and for those who have trouble with the math, the company admits with those sales that their stock is worth no more than $4.50 per share.
If you didn't listen to the conference call, he gave a good summary of the industry here and where ACB sits in it at thus link below. Hope this helps whatever decision you make. I am more pro acb and tilray and try to not be biased to only one side. Simply keep that in mind that in mind I'm a glass 1/2 full and am willing to take on risk where it may take a couple years to pay off.... it's worked for me in the past. I'm not sure if this will do down over the next 9 months, but I believe this market will be heating up alot as all these countries legalize.
https://www.cnbc.com/video/2022/02/10/were-the-number-one-medical-business-in-canada-aurora-cannabis-ceo-on-earnings.html
It's about time. Nice spike earlier today as well. If we go back up before close, I feel the message was well received by those listeners in the cc and we are moving up! Did you see where their San Raf which they make money on is what their new products are going to be based off in a few weeks? Also, it was pointed out the San Raf is increasing in sales, as expected. So value brands are still junk and they are not chasing it, where their premium products we make money on is increasing in sales numbers. I know you will say overall it's declining, but this is as expected if one listens to the cc. Many of the other LPs will be closing up shop in the rec market over the next few months, where that is when the Rec market should make businesses sense to look at again... that was my take away from the earnings in regards to the next few months on the rec side.
House Marijuana Banking Bill Sponsor Is ‘Confident’ It Will Advance Through Senate Despite Obstacles
February 11, 2022
The fight continues to get the Senate to pass a marijuana banking reform bill, and the measure’s House sponsor says he’s “confident” that the opposite chamber will finally take it up.
Rep. Ed Perlmutter (D-CO) has been trying to get the Secure and Fair Enforcement (SAFE) Banking Act across the finish line for several years now, and his latest attempt is to pass it as part of a large-scale manufacturing and innovation bill to which the cannabis language was recently attached in the House.
In an interview with Yahoo Finance on Friday, the congressman discussed the prospects of his proposal, which has cleared the House six times in some form now. He said that while Senate leadership has insisted on passing comprehensive legalization first, he still sees opportunities to advance his bipartisan incremental reform.
https://www.marijuanamoment.net/house-marijuana-banking-bill-sponsor-is-confident-it-will-advance-through-senate-despite-obstacles
It was promised 3 years ago, then 2 years ago, and then dangled 1 year ago. But it keeps being pushed out further and further. Now it is still at least 3 quarters away.
Trust the numbers, not the hype.
Next quarter, next year. Those are perpetually moving timeframes. Just remember, "Cam said so."
Depending who you ask. The new ceo who has been doing instead of putting out empty promises, and has been in this ceo position for about 1.6 years. He is the guy that put acb on the path to become stable and not treating ebita positive as a suggestion and taking it seriously among investors.
Looks like things are turning around.
May take a position here.
Thanks for all the great discussions.
It’s time we see that Positive EBITDA as promised last year or was that 2 years ago?
GLTA
I just listened to the cc again. The plan is working, the new brands coming out this spring are based off their brand which is both profitable and growing. 80m vs 60m is huge. I think we end green tomorrow. Guess we find out soon!
While the Canadian adult-use market continues to face challenges, we are focused on introducing a new range of products set to launch this spring," he concluded.
Medical cannabis net revenue1 was $45.7 million, an 18% increase from the prior year period, delivering 76% of Aurora's Q2 2022 consolidated revenue and 89% of adjusted gross profit.
Global cannabis net revenue of $60.6 Million
Adjusted EBITDA improved by 22% to a loss of $9.0 Million versus Q1 2022
Company reaffirms goal of adjusted EBITDA profitability by H1/2023
Transformation plan ahead of schedule; company now expects to realize upper end of $60 to $80 Million range in total cost savings by H1/2023; ~$60 million annualized savings implemented to date
Company remains #1 Canadian LP in global medical cannabis; international cannabis revenue increased 24% from Q1 2022
Fair? You may want to do some homework on Chainsaw Al Dunlap and the lessons of continuously looking to do a turnaround by cutting expenses without growing revenue. I'll give you a hint: massive failure except for management bonuses.
Fair? Aren't you the person who always said "But, Cam said so" when the truth became obvious and while the share price dropped 97% decided it was always "next quarter" when things would be good?
Fair? Management is looking for a buyout and will milk the bonuses as far as they can. They have absolutely no interest in the shareholders.
BTW, the hope of EBITDA positive is at least 3 quarters away according to management. The last time you jumped on the that bandwagon, you were burned badly because you trusted what management said.
Next quarter, next year. Those are perpetually moving timeframes.
I missed his cnbc interview... Hopefully catch it once its up online
Cc call is in 5 minutes! Link is in the earnings and a dozen other places!
Awesome as sga improving and ebita positive ahead and on the high end. Good things and bad things... be fair
Revenue flat, while others are growing!
Q1 revenue 60.1M. Q2 revenue 60.5M
All margins DOWN! (medical and consumer)
Q1 all pot margin: 54% Q2 all pot margin: 53%
Q1 med pot margin: 64% Q2 med pot margin: 62%
Q1 consumer pot margin: 32% Q2 consumer pot margin: 24%
Avg sales price down!
Q1:$4.67 Q2: $4.20
Yup, that transition plan is working, Not!
Imagine what it would have been if not for that one-time deal to Israel.
Global Cannabis Net Revenue of $60.6 Million
Adjusted EBITDA Improved by 22% to a loss of $9.0 Million versus Q1 2022
Company Reaffirms Goal of Adjusted EBITDA Profitability by H1/2023
Transformation Plan Ahead of Schedule; Company Now Expects to Realize Upper End of $60 to $80 Million Range in Total Cost Savings by H1/2023; ~$60 Million Annualized Savings Implemented to Date
Company Remains #1 Canadian LP in Global Medical Cannabis; International Cannabis Revenue Increased 24% from Q1 2022
https://www.newswire.ca/news-releases/aurora-cannabis-announces-fiscal-2022-second-quarter-results-835243824.html
And the USA us getting pretty close to get this through their senate. My guess is once it's going in for a vote all the Canadian cannabis companies will pop. Not sure if it will hold when it does as it will probably depend on the language and how companies like acb can do its business in the USA.
https://www.reddit.com/r/auroracannabis/comments/sp7kv8/new_this_am_senschumer_senbooker_and_ronwyden/?utm_source=share&utm_medium=ios_app&utm_name=iossmf
Just a reminder earnings are after the bell then the conference call. I'm not sure if I like the media pushing a beat. Investors in cgc seem to he happy with what they released yesterday, who started following acb's business plan on only going after higher margin premiums products as well(instead of making no money on the value brands). I think it's 50/50 we beat earnings as a case could be made on how it could go either way.
Maybe this time it will make it on through the senate. https://www.marijuanamoment.net/house-officially-approves-marijuana-banking-amendment-to-large-scale-bill-set-for-floor-action-on-friday/
So this is the highlights of last quarter. Hopefully we get a nice surprise with that 10m sale to cantek.
Transformation Plan On Track; Actions Taken-to-Date Have Driven Over $33 Million in Annualized Run-Rate Cost Savings
Total Cannabis Net Revenue, Net of Provisions, Grew ~10% to $60.1 million Compared to $54.8 Million in Q4 2021
Adjusted EBITDA Excluding Restructuring Costs Improved by $4.0 million to a loss of $11.5 million versus Q4 2021; Clear Pathway to Adjusted EBITDA Profitability by H1/FY23
Improved Adjusted Gross Margin before FVA of 54% versus 53% in Q4 2021
For what it's worth, I'm seeing this spread around more and more. My angle on it is that if we start seeing medical uses, it pretty much has a benefit to us shareholders as I believe once it's proven it indeed has medical value, it goes against what it's currently scheduled as... not saying legal like alcohol, as it could still be controlled going through pharmacies/prescriptions. ...aka medical marijuana.
Followers
|
895
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
70361
|
Created
|
11/09/15
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |